Dr. Kabraji is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2013 - 2017
Massachusetts General HospitalResidency, Internal Medicine, 2010 - 2013
Oxford University Medical SchoolClass of 2009
Certifications & Licensure
MA State Medical License 2012 - 2025
NY State Medical License 2023 - 2025- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 28 citationsPreclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases.Sheheryar Kabraji, Jing Ni, Sarah Sammons, Tianyu Li, Amanda E D Van Swearingen
Clinical Cancer Research. 2023-01-04 - 443 citationsALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non–Small Cell Lung CancerJustin F. Gainor, Anna M. Varghese, Sai-Hong Ignatius Ou, Sheheryar Kabraji, Mark M. Awad
Clinical Cancer Research. 2013-08-01 - 62 citationsDrug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?Sheheryar Kabraji, Jing Ni, Nan Lin, Shaozhen Xie, Eric P. Winer
Clinical Cancer Research. 2018-04-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
